EPISTAXIS
Clinical trials for EPISTAXIS explained in plain language.
Never miss a new study
Get alerted when new EPISTAXIS trials appear
Sign up with your email to follow new studies for EPISTAXIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New ointment could tame HHT nosebleeds
Symptom relief Recruiting nowThis early-phase trial tests a new nasal ointment called TOR-582, which contains sirolimus, in 27 adults with hereditary hemorrhagic telangiectasia (HHT) who have frequent nosebleeds. Participants apply the ointment inside their nostrils twice daily for 12 weeks, with different s…
Matched conditions: EPISTAXIS
Phase: PHASE1 • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Massive HHT registry aims to unlock secrets of rare bleeding disorder
Knowledge-focused Recruiting nowThis study creates a large registry of people diagnosed with hereditary hemorrhagic telangiectasia (HHT), a condition causing abnormal blood vessels and bleeding. Researchers will collect medical records and annual health updates for up to 10 years to understand how the disease c…
Matched conditions: EPISTAXIS
Sponsor: Cure HHT • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC